These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 30617773)

  • 21. Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma.
    Benhammou JN; Aby ES; Shirvanian G; Manansala K; Hussain SK; Tong MJ
    Sci Rep; 2020 Jun; 10(1):9902. PubMed ID: 32555268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC.
    Viganò L; Conci S; Cescon M; Fava C; Capelli P; D'Errico A; Torzilli G; Di Tommaso L; Giuliante F; Vecchio FM; Salizzoni M; David E; Pinna AD; Guglielmi A; Capussotti L
    J Hepatol; 2015 Jul; 63(1):93-101. PubMed ID: 25646890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.
    Wu SS; Shan QY; Xie WX; Chen B; Huang Y; Guo Y; Xie XY; Lu MD; Peng BG; Kuang M; Shen SL; Wang W
    Clin Transl Oncol; 2020 Mar; 22(3):401-410. PubMed ID: 31172445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes following laparoscopic versus open major hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score-matched analysis.
    Xu HW; Liu F; Li HY; Wei YG; Li B
    Surg Endosc; 2018 Feb; 32(2):712-719. PubMed ID: 28726140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
    Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW
    Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
    Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
    Sohn W; Paik YH; Cho JY; Ahn JM; Choi GS; Kim JM; Kwon CH; Joh JW; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    J Viral Hepat; 2015 Jun; 22(6):539-50. PubMed ID: 25377516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades.
    Liew ZH; Goh GB; Hao Y; Chang PE; Tan CK
    Dig Dis Sci; 2019 Feb; 64(2):585-590. PubMed ID: 30327962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis.
    Bengtsson B; Stål P; Wahlin S; Björkström NK; Hagström H
    Liver Int; 2019 Jun; 39(6):1098-1108. PubMed ID: 30829446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver resection versus microwave ablation for solitary and small (≤ 3 cm) HCC with early recurrence in different stages of liver cirrhosis: A propensity score matching study.
    Zhu RH; Huang Z; Xie ZH; Yuan T; Li J; Wang WQ; Lv X; Wang JL; Huang ZY; Zhang EL
    Asian J Surg; 2024 Jul; 47(7):3007-3014. PubMed ID: 38342723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver resection is justified for multinodular hepatocellular carcinoma in selected patients with cirrhosis: A multicenter analysis of 1,066 patients.
    Li ZL; Yu JJ; Guo JW; Sui CJ; Dai BH; Zhang WG; Chen TH; Li C; Gu WM; Zhou YH; Wang H; Zhang YM; Mao XH; Pawlik TM; Wang MD; Liang L; Wu H; Lau WY; Wu MC; Shen F; Yang T
    Eur J Surg Oncol; 2019 May; 45(5):800-807. PubMed ID: 30594407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
    Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
    J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease.
    Than NN; Ghazanfar A; Hodson J; Tehami N; Coldham C; Mergental H; Manas D; Shah T; Newsome PN; Reeves H; Shetty S
    QJM; 2017 Feb; 110(2):73-81. PubMed ID: 27634970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of post-operative complications after surgical resection of hepatocellular carcinoma and their prognostic effects on outcome and survival: A propensity-score matched and structural equation modelling study.
    Kabir T; Syn NL; Tan ZZX; Tan HJ; Yen C; Koh YX; Kam JH; Teo JY; Lee SY; Cheow PC; Chow PKH; Chung AYF; Ooi LL; Chan CY; Goh BKP
    Eur J Surg Oncol; 2020 Sep; 46(9):1756-1765. PubMed ID: 32345496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
    Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
    J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC.
    Li T; Wang SK; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
    Liver Int; 2016 Feb; 36(2):284-92. PubMed ID: 26104132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative impact of liver cirrhosis on robotic liver resection for hepatocellular carcinoma: a retrospective cohort study.
    Song S; Wang Z; Liu K; Zhang X; Zhang G; Zeng G; Zhu L; Yao Z; Hu M; Wang Z; Liu R
    Surg Endosc; 2024 Sep; 38(9):4926-4938. PubMed ID: 38977502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Child-Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection.
    Li C; Zhu WJ; Wen TF; Dai Y; Yan LN; Li B; Yang JY; Wang WT; Xu MQ
    J Gastrointest Surg; 2014 Aug; 18(8):1469-76. PubMed ID: 24903846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
    Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
    Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
    Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
    Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.